We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Vitamin C Deficiency Linked to Birth Complications

By Biotechdaily staff writers
Posted on 27 May 2002
In a study of "knockout mice” with markedly reduced levels of ascorbic acid, researchers found that the mice died within minutes after birth due to massive cerebral hemorrhage and complete respiratory failure. More...
The study was published in the May 2002 issue of Nature Medicine.

The researchers created a mouse model with a defective gene (Slc23a1) that encodes the protein that transports vitamin C into cells. They discovered that this knockout mouse could not deliver vitamin C from the blood to many fetal tissues nor transport it across the placental border. As a result, the gene-deficient mice had very reduced levels of ascorbic acid in their blood and very low levels in their brains and other organs. Massive cerebral bleeding and respiratory failure occurred whether the mice were delivered normally after 21 days' gestation or delivered early by cesarian section to avoid birth trauma.

The abnormalities in lung function were not due to loss of surfactant protein production since levels of a critical protein were found to be normal. Because 4-hydroxypoline levels were also normal, intracerebral hemorrhage due to vascular fragility and collagen processing deficiency from low vitamin C levels were also ruled out as possible causes. Also, while in the womb, the mice had developed normally.

"What I'm suggesting is that we need to take a look at whether vitamin C in human fetuses before birth, transported from the maternal circulation, is a normal physiologic factor that helps to mature and protect the lungs and brain of newborn infants,” said Dr. Robert Nussbaum, chief of the Genetic Disease Research at the National Human Genome Research Institute (NHGRI, Bethesda, MD, USA; www.nhgri.org) and co-author of the study.


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Prefilled Tubes
Prefilled 5.0ml Tubes
New
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more

Pathology

view channel
Image: Study flowchart. This study developed a multimodal artificial intelligence framework to predict PIK3CA mutations in breast cancer (Jiaxian Miao et al., Cancer Biol Med 23(3): 430–450 (2026). DOI: 10.20892/j.issn.2095-3941.2025.0771)

Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment

PIK3CA mutations are key biomarkers for selecting phosphoinositide 3-kinase (PI3K)–targeted therapies in breast cancer, yet access to molecular testing can be inconsistent and costly. Conventional polymerase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.